You are here

  • Home
  • Archive
  • Volume 67, Issue 5
  • Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial

Article metrics

Article menu
Download PDFPDF
Inflammatory bowel disease
Original article
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial

 

Online download statistics by month:

Online download statistics by month: April 2017 to March 2024

AbstractFullPdf
Apr 20172045228
May 2017493165136
Jun 20172206343
Jul 20171745043
Aug 20171353220
Sep 20171254627
Oct 20171763927
Nov 20171613322
Dec 20171241517
Jan 20181923733
Feb 20181022113
Mar 20181512815
Apr 20181590568219
May 201855110663
Jun 20183885237
Jul 20183053930
Aug 20182014630
Sep 20181803420
Oct 20182253420
Nov 20182343921
Dec 20181521615
Jan 20191812621
Feb 20191923433
Mar 20191352218
Apr 20191491511
May 20191821917
Jun 20191421710
Jul 20191801810
Aug 20191462515
Sep 20191301615
Oct 20191553521
Nov 20191021615
Dec 20191061110
Jan 2020100209
Feb 2020177196
Mar 20202171920
Apr 2020101148
May 202093105
Jun 20201262211
Jul 2020124109
Aug 2020113102
Sep 2020109126
Oct 202015677
Nov 20201311110
Dec 20206385
Jan 2021145118
Feb 2021198177
Mar 2021148148
Apr 2021131135
May 20218189
Jun 2021852
Jul 202123138
Aug 20211084
Sep 202121169
Oct 20211691413
Nov 2021127148
Dec 2021166134
Jan 2022187178
Feb 202217064
Mar 2022210185
Apr 2022203132
May 2022138138
Jun 2022230157
Jul 2022138142
Aug 202229152
Sep 2022203156
Oct 2022266217
Nov 2022178203
Dec 2022183162
Jan 2023112110
Feb 2023214135
Mar 2023178147
Apr 202312194
May 2023120164
Jun 20239293
Jul 202315541
Aug 202326191
Sep 202380112
Oct 2023129102
Nov 2023188125
Dec 20234741
Jan 202413386
Feb 202498118
Mar 202497113
Total1504224021366